MedPath

Kirby Institute

Kirby Institute logo
🇦🇺Australia
Ownership
Private
Established
1986-01-01
Employees
101
Market Cap
-
Website
https://kirby.unsw.edu.au

Clinical Trials

90

Active:5
Completed:55

Trial Phases

5 Phases

Phase 1:5
Phase 2:3
Phase 3:14
+2 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (63 trials with phase data)• Click on a phase to view related trials

Phase 4
27 (42.9%)
Not Applicable
14 (22.2%)
Phase 3
14 (22.2%)
Phase 1
5 (7.9%)
Phase 2
3 (4.8%)

Moxidectin Versus Ivermectin as Mass Drug Administration for the Control of Onchocerciasis and Other Neglected Tropical Diseases: A Cluster-randomised Trial

Not Applicable
Recruiting
Conditions
Onchocerciasis
Ascaris Lumbricoides Infection
Trichuris Trichiura; Infection
Hookworm Infections
Scabies
Interventions
First Posted Date
2025-08-28
Last Posted Date
2025-08-28
Lead Sponsor
Kirby Institute
Target Recruit Count
52000
Registration Number
NCT07145736
Locations
🇦🇴

Villages in Andulo and Nharea Municipalities, Andulo, Bíe Province, Angola

Optimising Metabolic Management for People With Human Immunodeficiency Virus (HIV) on Integrase Based Antiretroviral Therapy (ART)

Phase 3
Recruiting
Conditions
Weight Gain
HIV Infections
Interventions
First Posted Date
2024-03-19
Last Posted Date
2025-08-17
Lead Sponsor
Kirby Institute
Target Recruit Count
300
Registration Number
NCT06317051
Locations
🇲🇾

Universiti Malaya Medical Centre, Kuala Lumpur, Malaysia

🇿🇼

University of Zimbabwe Clinical Research Centre, Harare, Zimbabwe

🇦🇺

St Vincent's Hospital, Sydney, New South Wales, Australia

and more 5 locations

PATH Study: People With Injecting Related Infections: Assessing Treatment Outcomes for Those Who Are Hospitalised.

Not yet recruiting
Conditions
Infection, Fungal
Invasive Bacterial Infection
Infection, Soft Tissue
Invasive Fungal Infections
Injection Site Infection
Infection, Bacterial
First Posted Date
2024-01-23
Last Posted Date
2024-02-20
Lead Sponsor
Kirby Institute
Target Recruit Count
300
Registration Number
NCT06220370

National Prisons Hepatitis Education Project: Research Evaluation

Not Applicable
Recruiting
Conditions
HCV
First Posted Date
2023-07-12
Last Posted Date
2024-03-06
Lead Sponsor
Kirby Institute
Target Recruit Count
3000
Registration Number
NCT05942937
Locations
🇦🇺

Capricornia Correctional Centre, Rockhampton, Queensland, Australia

🇦🇺

Risdon Prison Complex, Hobart, Tasmania, Australia

Australian Hepatitis and Risk Survey in Prisons

Recruiting
Conditions
Hepatitis B
Hepatitis C
HIV Infections
First Posted Date
2023-05-03
Last Posted Date
2023-05-03
Lead Sponsor
Kirby Institute
Target Recruit Count
2400
Registration Number
NCT05839522
Locations
🇦🇺

Alexander Maconochie Centre, Hume, Australian Capital Territory, Australia

🇦🇺

Bathurst Correctional Complex, Bathurst, New South Wales, Australia

🇦🇺

John Morony Correctional Complex, Berkshire Park, New South Wales, Australia

and more 21 locations
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 18
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.